UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000021467
Receipt No. R000023157
Official scientific title of the study The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia
Date of disclosure of the study information 2016/03/14
Last modified on 2018/03/27 (Ver. 4)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia
Title of the study (Brief title) The effectiveness of prophylactic doses of intravenous nitroglycerin in preventing the incidence of myocardial ischemia under general anesthesia
Region
Japan

Condition
Condition myocardial ischemia
Classification by specialty
Anesthesiology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The purpose of this study was to evaluate whether prophylactic intravenous TNG can prevent the incidence of intraoperative myocardial ischemia for anesthesized patients. In addition, we also analyzed hemodynamic changes (heart rate [HR], mean blood pressure [MBP], and pulmonary capillary wedge pressure [PCWP]) from TNG in both pre and post anesthesia induction as an indicator of the decrease in preload.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes incidence of myocardial ischemia
Key secondary outcomes

Base
Study type Others,meta-analysis etc

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
100 years-old >=
Gender Male and Female
Key inclusion criteria This review included all randomized controlled trials investigating the incidence of MI associated with TNG compared with placebo in surgical patients.
Key exclusion criteria We excluded observational studies and those published as an abstract.
Target sample size 200

Research contact person
Name of lead principal investigator Hiroshi Hoshijima
Organization Saitama medical university hospital
Division name Anesthesiology
Address Saitama, Irumagunn, Moroyama, Morohongo38
TEL 049-276-1271
Email hhoshi@saitama-med.ac.jp

Public contact
Name of contact person Hiroshi Hoshijima
Organization Saitama medical university hospital
Division name Anesthesiology
Address Saitama, Irumagunn, Moroyama, Morohongo38
TEL 049-276-1271
Homepage URL
Email hhoshi@saitama-med.ac.jp

Sponsor
Institute Saitama medical university hospital, Anesthsiology
Institute
Department

Funding Source
Organization Saitama medical university hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 03 Month 14 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 04 Month 01 Day
Anticipated trial start date
2015 Year 05 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information The purpose of this study was to evaluate whether prophylactic intravenous TNG can prevent the incidence of intraoperative myocardial ischemia for anesthesized patients. In addition, we also analyzed hemodynamic changes (heart rate [HR], mean blood pressure [MBP], and pulmonary capillary wedge pressure [PCWP]) from TNG in both pre and post anesthesia induction as an indicator of the decrease in preload.

Management information
Registered date
2016 Year 03 Month 14 Day
Last modified on
2018 Year 03 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023157